title: Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension.
authors.affiliation: Institut de Recherche et de Formation CardioVasculaire, Paris, France.
authors.forename: Roland
authors.initials: R
authors.lastname: Asmar
authors.forename: Fady
authors.initials: F
authors.lastname: Sayegh
authors.forename: Wiesława
authors.initials: W
authors.lastname: Tracz
authors.forename: Marta
authors.initials: M
authors.lastname: Hlawaty
authors.forename: Maria
authors.initials: M
authors.lastname: Olszowska
authors.forename: Michel
authors.initials: M
authors.lastname: Jourde
authors.forename: Marc
authors.initials: M
authors.lastname: Vincent
authors.forename: Bernard
authors.initials: B
authors.lastname: Goujoun
authors.forename: Joao
authors.initials: J
authors.lastname: Maldonado
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D007546:Isoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D044005:Tetrahydroisoquinolines; D014463:Ultrasonography
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; C058302:moexipril